Introduction
l-(4-Morpholinomethyl)-tetrahydro-2(lH)-pyrimidinone (mopyridone, MCU) is an antiviral sub stance, synthesized by Sidzhakova et al. (1982) , which manifested a marked activity against alphaand orthomyxoviruses (Galabov et al., 1984 (Galabov et al., ,1994 . Noteworthy the inhibitory effect of the compound on replication of alphaviruses Semliki forest (SFV), Sindbis (SV) and Western equine encepha lomyelitis (W EEV) (Galabov et al., 1984; Karparov et al., 1986) . Moreover, mopyridone was highly efficient in vivo when administered intrave nously or subcutaneously in mice infected with SFV and SV, and a significant protection was re corded even at massive virus inocula (Karparov et al., 1985) . Recently, the compound given subcuta neously was found to be effective also in experi mental Eastern equine encephalomyelitis virus (EE E V ) infection in mice (A. A. Davydova, A. A. Lazarenko and I. F. Barinsky, unpublished data) . By its main chemotherapeutic characteristics mo pyridone could be considered as the most poten tial antiviral among known anti-alphavirus com pounds.
It was of interest to study the mopyridone effect on replication of another representative of Togaviridae family, the rubella virus.
Materials and Methods

Compound tested
Mopyridone (MCU, mol. weight 199.25, white fine crystals, very soluble in water) was supplied by D. Sidzhakova (Faculty of Pharmacy, Higher Medical School, Sofia).
Virus strains and cells
Two rubella virus strains were used, Judith (sup plied by the National Institute of Biological Stan dards and Control, London, U. K.) and RA27/3 (the Plotkin's vaccinal strain), cultivated in BHK2] (baby hamster kidney) cells from the collection of the National Institute of Biological Standards and Control, London (culture medium of Eagle's MEM Difco supplemented with 5% newborn calf serum).
Cytotoxicity test
The compound maximal tolerated (nontoxic, MTC) concentration for the cell culture was deter mined beforehand by tracing the effect of the com pound on uninfected confluent cell monolayer and cellular morphology for overt signs of cytotoxicity during 4 -5 days.
Antiviral tests
The compound effect was studied in a multicycle virus growth experimental setup. In this case the cell monolayers were inoculated at low values (0.005, 0.0005 and 0.00005) of multiplicity of infec tion (the number of viral infectious doses inocu lated per cell). Virus inoculum was added directly to the cell suspension at the time of seeding in test tubes. Compound at nontoxic concentrations was applied immediately after virus inoculation. Then, the infected cell cultures were observed during 7 days. The cytopathic effect (CPE) was scored on a 0 -4 basis with 4 representing total cell destruc tion. The infectious virus yields (in three times frozen and thawed cell culture samples) were as sayed on the 7th day after infection by the end point dilution method.
The CPE inhibition method using monolayer BHK2i cell cultures in 96-well plastic microplates (Flow, Glasgow) was used in some experiments with the Judith strain. The cells sheets were inocu lated with serial 1 0 -fold virus dilutions -1 -1 0 0 0 CCID50 (50% cell culture infectious doses), 0 . 0 2 ml per well, by 60 min adsorption at room temperature. Then the compound was added to the maintenance medium (0.2 ml per well of Dulbecco's MEM Sigma without serum) with 0.5 log10 increasing consecutive concentrations. The plates were incubated for 6 days and CPE was estimated as described above, the compound dose-response traced at 10-100 CCID50 viral dose. From the graphs the minimal concentration was evaluated causing a 50% reduction of CPE as compared to the untreated controls (MIC50).
Results and Discussion
Mopyridone, known as an alphavirus replication inhibitor, was tested vs. two rubella virus strains: the pathogenic Judith and the vaccinal RA27/3. No reference (control) substance was tested for comparison as, according to the literature data, a compound possessing a marked anti-rubella virus activity has not been described yet.
Initially the compound was studied in the multicycle virus growth setup applied at compara tively high concentrations, 200.7/401.4 îm, and the maximal tolerated concentration for BHK2] cells of 501.9 [xm had been found.
As seen in Table I , mopyridone showed a marked inhibitory effect on replication of the ru bella virus strains in BHK2j cells, expressed as suppression of CPE development and decrease of the infectious virus yield.
In further experiments the compound was tested against the Judith strain by the CPE inhibi tion method in 96-well microplates. The com pound activity was confirmed. A MIC50 value of 0.9 [im, and a selectivity ratio (MTC/MIC50) of 557.7, was established.
These data suggest mopyridone to be consid ered as a broad-spectrum inhibitor of togavirus replication. Obviously, the anti-rubella virus effect of this compound needs further elucidation. c CCID 50, infectious titer in 50% cell culture infectious doses.
